PureTech Health plc

    Jurisdiction
    United States
    LEI
    213800LVPDNO2Z9T9I39
    ISIN
    US7462371060 (PRTC)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €6.56M
    Gross margin
    35.7%
    EBIT
    -€241.73M
    EBIT margin
    -3,686.0%
    Net income
    -€10.18M
    Net margin
    -155.2%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    N/A -€105.02M +931.8%
    N/A -€95.76M -8.8%
    N/A -€146.64M +53.1%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: August 28, 2025

    Add to watchlist

    Notifications